HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could two HPV shots be enough? new study tests fewer doses for older women
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether two doses of the HPV vaccine work as well as three doses for women aged 27 to 45. About 618 women will be randomly assigned to receive either two or three shots. The goal is to see if the immune response from two doses is strong enough to protect again…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:58 UTC
-
New HPV test aims to make screening quick and easy
Diagnosis Recruiting nowThis study is testing a new point-of-care HPV test that requires less equipment than current tests, potentially making screening more accessible. Researchers will compare the new test's results with standard lab tests using samples from 600 participants. The goal is to see if the…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 14:01 UTC
-
Scientists hunt for genetic clues to severe HPV infections
Knowledge-focused Recruiting nowThis study aims to understand why some people develop severe, recurring HPV-related warts or lesions that do not respond to standard treatments. Researchers will collect medical history, blood, tissue, and other samples from 850 participants aged 3 and older, including healthy re…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC